PDE5A and glioblastoma: Moreover, performing an expression analysis of cell lines derived from primary and recurrent GBM with resistance to the O(6)-alkylating agents bis(chloroethyl)nitrosourea (BCNU) and TMZ [26], we found that cell lines obtained from recurrent gliomas showed lower PDE5 mRNA expression (Figure 2D).